Observer Observer Logo

AstraZeneca

  • Business
  • |
  • Arts
  • |
  • Entertainment
  • |
Newsletters
  • Entertainment
    • What to Watch
    • Books
    • Reviews
    • Movies
    • TV
    • Theater
    • Music
  • Arts
    • Visual Art
  • Business
    • Management
    • Media
    • Technology
    • Space
  • Lifestyle
    • Fashion
    • Travel
    • Beauty
  • About
    • Masthead
    • Editorial Ethics and Guidelines
    • Advertise With Us
    • Observer Advertising Guidelines
Events Newsletters

AstraZeneca

Apr 21

Big Pharma CEOs Profited Millions From COVID-19 Vaccines—Except For One

BioNTech founder Uğur Şahin hasn't sold one company share since February 2020.
By Sissi Cao
Apr 20

The Next-Generation COVID-19 Vaccine: Every Variant-Targeting Shot In Development

There are three COVID-19 strains of concern right now: B.117, P.1 and B.1.351.
By Sissi Cao
Apr 13

Don’t Freak Out Over CDC’s Johnson & Johnson Vaccine Pause, Doctors Say

"I got the J&J vaccine 8 days ago. I’m not losing sleep over this," said a Columbia virologist.
By Sissi Cao
Apr 8

What’s The Deal With The Oxford-AstraZeneca Vaccine? Is It Really That Bad?

By Sissi Cao
Mar 12

Which COVID-19 Vaccine Is Best? Comparing Pfizer, Moderna, J&J, Novavax, AstraZeneca

By Sissi Cao
Feb 8

When Will the Pandemic End? This Vaccine Data-Backed Outlook Will Make You Cry

By Sissi Cao
Dec 28

AstraZeneca’s COVID-19 Vaccine, Approved in the UK, Could Have a Huge Impact

By Jordan Zakarin
Dec 4

New COVID-19 Vaccine Data Shows It May Be Effective For Up to a Year

By Sissi Cao
Nov 23

COVID-19 Vaccine Prices Revealed From Pfizer, Moderna, and AstraZeneca

By Sissi Cao
Oct 29

Moderna, Pfizer Say They’re Close to COVID-19 Vaccine, But Huge Problems Remain

By Sissi Cao
Oct 20

Here Are All the Side Effects of Every Top COVID-19 Vaccine in US

By Sissi Cao
Oct 3

We Won’t Have a Working COVID-19 Vaccine in ‘Weeks’ Like Trump Promised

By Sissi Cao
Aug 24

A COVID-19 Vaccine May Get Fast-Tracked, But Reinfection Poses New Risk

By Sissi Cao
Jul 27

The US Has Pledged $5 Billion To Pharma Giants for a COVID-19 Vaccine. Who Will Win?

By Sissi Cao
Jul 21

Former FDA Officer Weighs in on 1st COVID-19 Vaccine’s Available Date, Price

By Sissi Cao
Jul 16

Coronavirus Vaccine Race Gets Desperate: Johnson & Johnson Posts Losses, Cases Spike

By Sissi Cao
Jul 7

How Novavax Stock Surged 2,500% On COVID-19 Vaccine Dreams, Without Any Track Record

By Sissi Cao
Jun 16

‘Breakthrough’ COVID-19 Treatment Emerges As Vaccines Get Closer to Authorization

By Sissi Cao
May 26

Bill Gates Funds a Crucial COVID-19 Vaccine Human Trial, Merck Adds 2 Candidates

By Sissi Cao
Feb 27

Coronavirus Outbreak Will Send Drug Prices Soaring, Health Care Experts Warn

By Andy Hirschfeld
  • Contact
  • About
  • Advertise
  • Advertising Guidelines
  • Editorial Ethics
  • Sitemap
  • Newsletters
  • RSS Feeds
  • Privacy
  • Terms
  • Cookie Settings
  • Do not sell my data
Powered by WordPress VIP

We noticed you're using an ad blocker.

We get it: you like to have control of your own internet experience.
But advertising revenue helps support our journalism.

To read our full stories, please turn off your ad blocker.
We'd really appreciate it.

How Do I Whitelist Observer?

How Do I Whitelist Observer?

Below are steps you can take in order to whitelist Observer.com on your browser:

For Adblock:

Click the AdBlock button on your browser and select Don't run on pages on this domain.

For Adblock Plus on Google Chrome:

Click the AdBlock Plus button on your browser and select Enabled on this site.

For Adblock Plus on Firefox:

Click the AdBlock Plus button on your browser and select Disable on Observer.com.

Then Reload the Page